[Music] Joining me now, John Carney, financial journalist and first time on set, Neil Betta, Ren Mack, head of economic research. Gentlemen, thank you, Neil. What do you think of the story.I'm just going to give you open field running. Start us off, please, in honor of your appearance. Well, thanks for having me on, Larry.It's an honor. Um, you know, look, I would just say if you had to look at the markets, stocks are basically at records. the uh bond market is basically pricing in a more rapid path back to ...

The world's top chocolatier Barry Callebaut must reduce its debt and is working to achieve this, CEO Peter Feld was quoted as saying in an interview published on Thursday. ...

Cracker Barrel Old Country Store Inc. CBRL is bracing for a $25 million financial impact from the Donald Trump administration’s tariffs in the coming fiscal year, forcing the company to significantly reduce the number of products in its famous gift shops and aggressively renegotiate deals with its suppliers.Cracker Barrel fell in after-hours. Check out the stock price here.CBRL To Reduce Store Products By 10% To Fight TariffsThe strategy was detailed by executives during the company's fourth-quarter earning ...

Core Viewpoint - Novo Nordisk's late-stage trial results for its oral obesity pill demonstrate significant weight reduction and tolerability, comparable to its existing Wegovy injection, highlighting the company's advancement in obesity treatment options [1][2]. Group 1: Trial Results - The phase 3 Oasis 4 trial indicated that the oral semaglutide pill resulted in an average weight reduction of 16.6% after 64 weeks in patients with obesity or overweight and at least one weight-related comorbidity [2]. - The oral treatment, referred to as the "Wegovy pill," provides an important alternative to the existing once-weekly injection, according to Novo Nordisk's Chief Science Officer [2][3]. Group 2: Efficacy and Safety - The company successfully demonstrated that the oral tablet can achieve the same efficacy, safety, and tolerability as the injectable version, allowing patients to choose between the two forms of treatment [3]. - The oral treatment utilizes the same Semaglutide GLP-1 medication that is the foundation of Novo Nordisk's current obesity and diabetes treatments, Wegovy and Ozempic [4]. Group 3: Regulatory Status and Production - The oral pill is currently under review by the U.S. Food and Drug Administration, with a decision expected in the fourth quarter of this year following its New Drug Application submission in February [5]. - If approved, the production of the pill will be fully based in the U.S., aligning with the trend of global pharmaceutical firms increasing their investments in U.S. manufacturing [5].

Core Insights - SoftBank's joint venture with OpenAI to provide AI services to corporate clients in Japan is significantly delayed [1] Group 1 - The joint venture aims to deliver artificial intelligence solutions to businesses in Japan [1] - The project is reportedly behind schedule, indicating potential challenges in execution [1]

Core Insights - Elkem ASA has initiated a strategic review of its Silicones division to streamline operations and enhance capital allocation for growth in its Silicon Products and Carbon Solutions divisions [1] Company Strategy - The strategic review aims to enable Elkem to focus on accelerating growth in its Silicon Products and Carbon Solutions divisions [1]

Group 1 - Husqvarna Group will hold its Capital Markets Day on December 10, 2025, at the IVA Conference Center in Stockholm, providing insights into the company's strategic priorities and progress [1][2] - The event will feature presentations from CEO Glen Instone, CFO Terry Burke, and other management team members, showcasing the Group's market-leading products and innovations [1] - For those unable to attend in person, the presentations will be available via live online broadcast, with recordings and slides published on the company's website the day after the event [3] Group 2 - Husqvarna Group is a global leader in innovative solutions for managing forests, parks, and gardens, as well as construction equipment and diamond tools [4] - The company reported net sales of SEK 48.4 billion in 2024 and operates under the Husqvarna and Gardena brands, serving consumers and professionals in over 100 countries [4] - Husqvarna Group employs approximately 12,300 people across 40 countries and is listed on Nasdaq Stockholm [4] Group 3 - Omar Attar has been appointed as the interim President of the Husqvarna Forest and Garden Division, effective immediately [6] Group 4 - The second quarter of 2025 saw a 1% decrease in net sales to SEK 15,277 million compared to SEK 15,430 million in the previous year [7]

Crude Value Insights offers you an investing service and community focused on oil and natural gas. We focus on cash flow and the companies that generate it, leading to value and growth prospects with real potential.Subscribers get to use a 50+ stock model account, in-depth cash flow analyses of E&P firms, and live chat discussion of the sector.Sign up today for your two-week free trial and get a new lease on oil & gas! ...

Huawei Technologies unveiled its SuperPod technology on Thursday, combining AI chips with over 15,000 graphics cards, demonstrating a supercluster with 1 million graphics cards, according to media reports. The move signals a direct challenge to Nvidia's (NASDAQ:NVDA) dominance in large-scale ...

Group 1 - The article emphasizes the importance of research-driven insights for retail investors [1] - It highlights the potential for savings on subscription fees for investment services [1] - The author expresses a personal interest in initiating a long position in ALMU within the next 72 hours [1] Group 2 - The article does not provide specific investment recommendations or advice [2] - It clarifies that past performance is not indicative of future results [2] - The authors of the articles may not be licensed or certified by any regulatory body [2]